Clinical Trials Directory

Trials / Conditions / Kaposi's Sarcoma

Kaposi's Sarcoma

24 registered clinical trials studyying Kaposi's Sarcoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingMolecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune
NCT03300830
National Cancer Institute (NCI)—
UnknownPhase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma
NCT02212639
Assistance Publique - Hôpitaux de ParisPhase 2
CompletedEvaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by
NCT02201420
Navidea BiopharmaceuticalsPhase 2
CompletedA Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
NCT02029430
ImmunityBio, Inc.Phase 2
CompletedAntiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-rela
NCT01352117
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsPhase 3
CompletedEffects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
NCT01276236
University of California, San FranciscoPhase 2
Completed124I-FIAU Imaging in EBV and KSHV Associated Cancers
NCT00982449
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsN/A
CompletedIntralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
NCT01296815
Centro de Investigación en. Enfermedades Infecciosas, MexicoPhase 2
TerminatedPTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
NCT00686842
AIDS Malignancy ConsortiumPhase 1 / Phase 2
CompletedTreatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
NCT01067690
Barbara Ensoli, MD, PhDPhase 2
CompletedAnti-Retrovirals for Kaposi's Sarcoma
NCT00444379
University of California, San FranciscoPhase 4
TerminatedBAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
NCT00287495
National Cancer Institute (NCI)Phase 1
CompletedBevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
NCT00055237
National Cancer Institute (NCI)Phase 2
CompletedHIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT
NCT00380770
University of KwaZuluPhase 4
CompletedRisk Factors for Non-HIV-Related Kaposi s Sarcoma
NCT00339326
National Cancer Institute (NCI)—
CompletedAssessment of Blood Vessel Density in Kaposi's Sarcoma Lesions
NCT00026793
National Cancer Institute (NCI)—
CompletedSeroprevalence of Kaposi's Sarcoma Herpes Virus in the United States
NCT00026728
National Cancer Institute (NCI)—
RecruitingSpecimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions
NCT00006518
National Cancer Institute (NCI)—
CompletedEffects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
NCT00006171
National Cancer Institute (NCI)—
CompletedOptical Biopsy of Human Skin in Conjunction With Laser Treatment
NCT00540566
University of California, Irvine—
CompletedSpectroscopy With Surface Coils and Decoupling
NCT00581815
Memorial Sloan Kettering Cancer CenterPhase 1
CompletedClinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
NCT00001560
National Cancer Institute (NCI)—
CompletedTwins Study of Gene Therapy for HIV Infection
NCT00001535
National Human Genome Research Institute (NHGRI)Phase 1
CompletedGenetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alc
NCT00001294
National Cancer Institute (NCI)—